C. Grand-ouest, Réseau Epigénétique (RepiCGO)

. Cnrs,

;. Faculté-de-médecine, E. Prieto-garcia, C. V. Diaz-garcia, I. Garcia-ruiz, and M. T. Agullo-ortuno, Epithelial-to-mesenchymal transition in tumor progression, Clinical Investigation Center in Biotherapy, F-25000 Besançon, France. 11 DimaCell Platform, vol.1, p.122, 2017.

W. Li, Methylation-mediated silencing of microRNA-211 promotes cell growth and epithelial to mesenchymal transition through activation of the AKT/beta-catenin pathway in GBM, Oncotarget, vol.8, pp.25167-25176, 2017.

Q. Li, KDM6B induces epithelial-mesenchymal transition and enhances clear cell renal cell carcinoma metastasis through the activation of SLUG, Int. J. Clin. Exp. Pathol, vol.8, pp.6334-6344, 2015.

F. Yang, SET8 promotes epithelial-mesenchymal transition and confers TWIST dual transcriptional activities, EMBO J, vol.31, pp.110-123, 2012.

R. M. Gemmill, ZEB1-responsive genes in non-small cell lung cancer, Cancer Lett, vol.300, pp.66-78, 2011.

Y. Yamauchi, Tumor necrosis factor-alpha enhances both epithelialmesenchymal transition and cell contraction induced in A549 human alveolar epithelial cells by transforming growth factor-beta1, Exp. Lung Res, vol.36, pp.12-24, 2010.

J. Kim, J. Kong, H. Chang, H. Kim, and A. Kim, EGF induces epithelialmesenchymal transition through phospho-Smad2/3-Snail signaling pathway in breast cancer cells, Oncotarget, vol.7, pp.85021-85032, 2016.

Y. Wu, Stabilization of snail by NF-kappaB is required for inflammationinduced cell migration and invasion, Cancer Cell, vol.15, pp.416-428, 2009.

A. Asgarova, PD-L1 expression is regulated by both DNA methylation and NF-kB during EMT signaling in non-small cell lung carcinoma, Oncoimmunology, vol.7, p.1423170, 2018.

M. L. Taddei, E. Giannoni, G. Comito, and P. Chiarugi, Microenvironment and tumor cell plasticity: an easy way out, Cancer Lett, vol.341, pp.80-96, 2013.

J. S. Parker, Supervised risk predictor of breast cancer based on intrinsic subtypes, J. Clin. Oncol, vol.27, pp.1160-1167, 2009.

S. J. Serrano-gomez, M. Maziveyi, and S. K. Alahari, Regulation of epithelialmesenchymal transition through epigenetic and post-translational modifications, Mol. Cancer, vol.15, p.18, 2016.

A. C. Mullen, Master transcription factors determine cell-type-specific responses to TGF-beta signaling, Cell, vol.147, pp.565-576, 2011.

L. Du, Transcriptome profiling reveals novel gene expression signatures and regulating transcription factors of TGFbeta-induced epithelial-tomesenchymal transition, Cancer Med, vol.5, pp.1962-1972, 2016.

M. Cieslik, Epigenetic coordination of signaling pathways during the epithelial-mesenchymal transition, Epigenetics Chromatin, vol.6, p.28, 2013.

Z. Q. Lang, Y. Q. Wu, X. B. Pan, G. M. Qu, and T. G. Zhang, The identification of multifocal breast cancer-associated long non-coding RNAs, Eur. Rev. Med. Pharmacol. Sci, vol.21, pp.5648-5654, 2017.

Y. Han, HOXA13 contributes to gastric carcinogenesis through DHRS2 interacting with MDM2 and confers 5-FU resistance by a p53-dependent pathway, Mol. Carcinog, vol.57, pp.722-734, 2018.

M. Wang, Large-scale association analysis in Asians identifies new susceptibility loci for prostate cancer, Nat. Commun, vol.6, p.8469, 2015.

R. Schneider, Histone H3 lysine 4 methylation patterns in higher eukaryotic genes, Nat. Cell Biol, vol.6, pp.73-77, 2004.

D. H. Kim, Histone H3K27 trimethylation inhibits H3 binding and function of SET1-like H3K4 methyltransferase complexes, Mol. Cell. Biol, vol.33, pp.4936-4946, 2013.

H. W. Lo, Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression, Cancer Res, vol.67, pp.9066-9076, 2007.

A. Bonnomet, A dynamic in vivo model of epithelial-to-mesenchymal transitions in circulating tumor cells and metastases of breast cancer, Oncogene, vol.31, pp.3741-3753, 2012.

R. Cao, Elevated expression of myosin X in tumours contributes to breast cancer aggressiveness and metastasis, Br. J. Cancer, vol.111, pp.539-550, 2014.

M. J. Duffy, E. Mckiernan, N. O'donovan, and P. M. Mcgowan, Role of ADAMs in cancer formation and progression, Clin. Cancer Res, vol.15, pp.1140-1144, 2009.

X. Wang, MiR-145 inhibits the epithelial-to-mesenchymal transition via targeting ADAM19 in human glioblastoma, Oncotarget, vol.8, pp.92545-92554, 2017.

H. Mi, PANTHER version 11: expanded annotation data from Gene Ontology and Reactome pathways, and data analysis tool enhancements, Nucleic Acids Res, vol.45, pp.183-189, 2017.

V. Gnemmi, MUC1 drives epithelial-mesenchymal transition in renal carcinoma through Wnt/beta-catenin pathway and interaction with SNAIL promoter, Cancer Lett, vol.346, pp.225-236, 2014.

C. Chen, S. S. Khaleel, H. Huang, and C. H. Wu, Software for pre-processing Illumina next-generation sequencing short read sequences, Source Code Biol. Med, vol.9, 2014.

C. Zang, A clustering approach for identification of enriched domains from histone modification ChIP-Seq data, Bioinformatics, vol.25, pp.1952-1958, 2009.

W. Huang, R. Loganantharaj, B. Schroeder, D. Fargo, and L. Li, PAVIS: a tool for Peak Annotation and Visualization, Bioinformatics, vol.29, pp.3097-3099, 2013.

S. Wang, Target analysis by integration of transcriptome and ChIP-seq data with BETA, Nat. Protoc, vol.8, pp.2502-2515, 2013.

F. Ramirez, deepTools2: a next generation web server for deepsequencing data analysis, Nucleic Acids Res, vol.44, pp.160-165, 2016.

A. Subramanian, Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles, Proc. Natl. Acad. Sci. USA, vol.102, pp.15545-15550, 2005.

M. Herfs, Proteomic signatures reveal a dualistic and clinically relevant classification of anal canal carcinoma, J. Pathol, vol.241, pp.522-533, 2017.

P. Hubert, Altered alpha-defensin 5 expression in cervical squamocolumnar junction: implication in the formation of a viral/tumour-permissive microenvironment, J. Pathol, vol.234, pp.464-477, 2014.